Fundamentals Data provided by Morningstar.
52 Week Range
Avg. Volume (1 month)
as at 24 Feb 3:44pm
Why Citadel, Coles, Nearmap, & WiseTech Global are tumbling lower
Share Market News
Citadel announces half year results and $200 million healthcare acquisition
Share Market News
ALL ORDINARIES finishes lower Monday: 8 ASX shares you missed
Why the Citadel share price is racing higher on Monday
Share Market News
Why Citadel, Evolution, PolyNovo, & Pro Medicus shares are charging higher
2 ASX tech shares that could fly in 2020
What top ASX shares are analysts eyeing up for 2020?
Here’s why the Citadel share price rose almost 4%
|07 Dec 2020||$0.2000||100.00%||Special Cash||17 Dec 2020|
|02 Sep 2020||$0.0600||100.00%||Final||01 Oct 2020|
|25 Feb 2020||$0.0480||100.00%||Interim||27 Mar 2020|
|23 Aug 2019||$0.0600||100.00%||Final||27 Sep 2019|
|22 Feb 2019||$0.0480||100.00%||Interim||29 Mar 2019|
|23 Aug 2018||$0.0900||100.00%||Final||28 Sep 2018|
|22 Feb 2018||$0.0480||100.00%||Interim||29 Mar 2018|
|24 Aug 2017||$0.0800||100.00%||Final||29 Sep 2017|
|23 Feb 2017||$0.0480||100.00%||Interim||31 Mar 2017|
|25 Aug 2016||$0.0480||100.00%||Final||30 Sep 2016|
|24 Feb 2016||$0.0480||100.00%||Interim||31 Mar 2016|
|27 Aug 2015||$0.0580||100.00%||30 Sep 2015|
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
|Date||Announcement||Price Sensitive?||Time||No. of Pages||File Size|
|Ms Jayne Andrea Shaw||Non-Executive Director||Jun 2020||
Ms Shaw brings to the Board not only her experience in healthcare management, but also an experienced clinical background in nursing. Jayne has acted in senior management roles in two Australian private hospitals and established an Australian and international consulting business which was sold to Healthsouth, a large US Healthcare company. After this, Jayne became the co-founder of Vision Group, a business that was successfully listed on the ASX.
Jayne has been a member of a number of private healthcare boards involved with specialist consolidation including cardiology, cancer care, orthopaedics, and women's health and has continued to work with private equity firms on local and international healthcare transactions.
Jayne also holds positions on the boards of Mable Technologies, the Woolcock Research Institute, and The Hareda Foundation, and as Chairman of BCAL Diagnostics. She is also Member of Risk and Compliance Committee.
|Mr Lt-Gen Peter Francis Leahy||Non-Executive DirectorNon-Executive Chairman||Jun 2014||
Lt-Gen Leahy retired from the Australian Army in July 2008, after a 37-year career. He retired as a Lieutenant General in the position of Chief of Army, a position he held for 6 years. In this appointment he was directly accountable for Army's $6 billion annual budget and his responsibilities included the detailed management of personnel, operating and capital cost centres and the direct responsibility to raise, train and sustain the Army. He was the principal adviser to the Chief of the Defence Force on strategic matters related to the deployment of the Army on global combat operations. He is now a Professor and Foundation Director of the National Security Institute at the University of Canberra.
He is a technical adviser to the board of WarpForge Limited.
In work related to charities he is the Chairman of Soldier On, Salvation Army Red Shield Appeal Committee in the ACT and the Australian Student Veterans Association.
Lt Gen Peter Leahy's qualifications include UNSW, USACGS and Fellow, Australian Centre for Defence and Strategic Studies. He is also Member of Risk and Compliance Committee.
|Mr Mark Steven McConnell||Chief Executive OfficerManaging Director||Jul 2016||
Mr McConnell is a business developer whose skills cover areas of business strategy, investor relations, capital raising and innovation. After serving as an officer in the Royal Australian Air Force for 8 years, Mark moved into the corporate world in 1997 and has worked across various executive roles in the fields of aviation, technology and investment banking. In 2007, he founded and ran New Territories Investments, a private equity fund that has assisted the growth strategies of multiple technology businesses in Australia, including Citadel.
Mark was awarded the ACT Young Entrepreneur of the Year in 2003 and 2006.
He is also director and deputy Chair of Cricket ACT (Inc), a board adviser to HOF Capital and a committee member of the Red Shield Appeal.
|Mr Robert Ian Alexander||Non-Executive Director||Dec 2019||
Mr Alexander is an experienced senior executive and director with over 30 years experience working in the commercial sector, primarily in sectors undergoing significant digital and technology transformation. Bob has worked in global organisations in industries such as media, entertainment, professional services, intellectual property and the print industry. He has considerable experience in corporate governance, mergers and acquisitions, and has led numerous transactions and the integration of acquired businesses. Bob is an Executive board and committee member of the Cambodian Children's Fund (Hong Kong) and Cambodian Children's Fund Australia Inc. He sits on the advisory board of Tablo.io, a digital platform connecting authors and readers. Bob is a leader in corporate social responsibility and is an Executive Board Member of the Cambodian Children's Fund, overseeing global strategy, organisational development, IT infrastructure and systems with global responsibility for fundraising and operations. He was previously a Non-executive Director of QMS Media Ltd and a Non-executive Director and Chairman of the Audit and Risk Committee of Xenith IP Group Ltd. He is also Chair of Risk and Compliance Committee.
|Mrs Jennifer(Jenny) Martin||Chief Financial OfficerJoint Company Secretary||Aug 2018||
|Mr Spencer Chipperfield||Company Secretary||Mar 2019||
|Jennifer(Jenny) Martin||Chief Financial OfficerJoint Company Secretary||
|Spencer Chipperfield||Company Secretary||
|J P Morgan Nominees Australia Pty Limited||7,911,321||10.05%|
|Hsbc Custody Nominees (Australia) Limited||7,253,382||9.22%|
|National Nominees Limited||6,817,636||8.66%|
|Citicorp Nominees Pty Limited||5,952,365||7.56%|
|Equitas Nominees Pty Limited||5,476,181||6.96%|
|Bnp Paribas Nominees Pty Ltd||2,943,387||3.74%|
|PJA Australia Pty Ltd||2,753,095||3.50%|
|Ubs Nominees Pty Ltd||1,355,435||1.72%|
|Capital Property Corporation Pty Ltd||1,246,521||1.58%|
|Brispot Nominees Pty Ltd||1,230,125||1.56%|
|Cs Fourth Nominees Pty Limited||1,090,459||1.39%|
|HSBC Custody Nominees (Australia) Limited A/C 2||984,489||1.25%|
|Christopher Paul Yeowart||938,792||1.19%|
|Bnp Paribas Noms Pty Ltd||833,835||1.06%|
|Jakeman Holding Co Pty Ltd||800,000||1.02%|
|Graham Paul Ridgway||732,009||0.93%|
|Citicorp Nominees Pty Limited i||689,000||0.88%|
|National Nominees Limited i||639,052||0.81%|
|Abbysah Pty Limited||500,000||0.64%|